Terumo Interventional Systems Announces Line Expansion of Its Pinnacle® Destination® Guiding Sheaths 8 French Size Extends Product Use in Atherectomy and Stent Graft Procedures
September
13, 2009 -- Somerset, New Jersey -- Terumo Interventional
Systems has announced the expansion of its Pinnacle® Destination® Guiding
Sheaths. The introduction of the 8F Destination Guiding Sheath
extends
the range of interventional procedures that can be performed
by this market-leading product to include atherectomy and stent
graft procedures.
The Pinnacle Destination Guiding Sheath line supports
virtually all applicable diagnostic and interventional procedures.
This highly respected
established brand offers a comprehensive range of French sizes
(5F – 8F), lengths and tip shapes as well as two different valve
types.
“Pinnacle Destination is reliably consistent and extremely durable. The addition of the 8F size helps me expand the types of cases I can perform with confidence, providing me with a device that creates an environment that can withstand challenging manipulations often required to deliver devices,” remarked Barry Weinstock, M.D. “The very first case I tried was a complex case in very challenging anatomy and the Destination allowed me to achieve an excellent result.”
The Pinnacle Destination design includes a unique atraumatic tip, which minimizes the potential for vessel damage, allows smooth transition from guidewire to dilator and dilator to sheath, helping to ensure easy penetration without force. The sheath has a hydrophilic coating on a nylon outer layer, with a PTFE inner layer and stainless steel coil.
“The Pinnacle Destination line is well-recognized for its exceptional trackability, durability and kink resistance,” said Susan Anderson, Marketing Manager, Lesion Access. “The 8F size is a direct result of physician input and demand for this product in addressing the surging number of limb salvage and stent graft cases.”
Terumo’s Pinnacle product line, manufactured by Terumo in its Maryland plant, has long been viewed as the “gold standard” in guiding sheaths.
For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800.862.4143 or by visiting http://www.terumois.com.
Terumo Interventional Systems
Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.
Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists, and Vascular Surgeons are among the medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions, thereby allowing therapeutic intervention in previously unreachable vascular beds.
Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide.
Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $3.0 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s leading stock index.
Source: Terumo Interventional Systems
(Disclaimer: external
links to news, press releases and other timely information
sources are provided as a service by Angioplasty.Org, which
is not responsible for the content found on any external
sites. Items marked with a ($$) indicate that the external
site normally restricts viewing to paid subscribers. Other
sites may require free registration.
